BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1180 related articles for article (PubMed ID: 34368071)

  • 1. Toward Achieving a Vaccine-Derived Herd Immunity Threshold for COVID-19 in the U.S.
    Gumel AB; Iboi EA; Ngonghala CN; Ngwa GA
    Front Public Health; 2021; 9():709369. PubMed ID: 34368071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unraveling the dynamics of the Omicron and Delta variants of the 2019 coronavirus in the presence of vaccination, mask usage, and antiviral treatment.
    Ngonghala CN; Taboe HB; Safdar S; Gumel AB
    Appl Math Model; 2023 Feb; 114():447-465. PubMed ID: 36281307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Will an imperfect vaccine curtail the COVID-19 pandemic in the U.S.?
    Iboi EA; Ngonghala CN; Gumel AB
    Infect Dis Model; 2020; 5():510-524. PubMed ID: 32835142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mathematical assessment of the impact of non-pharmaceutical interventions on curtailing the 2019 novel Coronavirus.
    Ngonghala CN; Iboi E; Eikenberry S; Scotch M; MacIntyre CR; Bonds MH; Gumel AB
    Math Biosci; 2020 Jul; 325():108364. PubMed ID: 32360770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical assessment of the impact of vaccine-type and immunity on the burden of COVID-19.
    Taboe HB; Asare-Baah M; Iboi EA; Ngonghala CN
    Math Biosci; 2023 Jun; 360():108981. PubMed ID: 36803672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mathematical assessment of the roles of age heterogeneity and vaccination on the dynamics and control of SARS-CoV-2.
    Pant B; Gumel AB
    Infect Dis Model; 2024 Sep; 9(3):828-874. PubMed ID: 38725431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mathematical assessment of the role of waning and boosting immunity against the BA.1 Omicron variant in the United States.
    Safdar S; Ngonghala CN; Gumel AB
    Math Biosci Eng; 2023 Jan; 20(1):179-212. PubMed ID: 36650762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Could masks curtail the post-lockdown resurgence of COVID-19 in the US?
    Ngonghala CN; Iboi EA; Gumel AB
    Math Biosci; 2020 Nov; 329():108452. PubMed ID: 32818515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of age structure and vaccine prioritization on COVID-19 in West Africa.
    Taboe HB; Asare-Baah M; Yesmin A; Ngonghala CN
    Infect Dis Model; 2022 Dec; 7(4):709-727. PubMed ID: 36097593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Will vaccine-derived protective immunity curtail COVID-19 variants in the US?
    Mancuso M; Eikenberry SE; Gumel AB
    Infect Dis Model; 2021; 6():1110-1134. PubMed ID: 34518808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the impact of widespread respirator use in curtailing COVID-19 transmission in the USA.
    Ngonghala CN; Knitter JR; Marinacci L; Bonds MH; Gumel AB
    R Soc Open Sci; 2021 Sep; 8(9):210699. PubMed ID: 34527275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herd immunity: challenges and the way forward in Korea.
    Oh J; Kim S; Ryu B; Shin M; Kim BI
    Epidemiol Health; 2021; 43():e2021054. PubMed ID: 34412446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of vaccine prioritization strategies on mitigating COVID-19: an agent-based simulation study using an urban region in the United States.
    Tatapudi H; Das R; Das TK
    BMC Med Res Methodol; 2021 Dec; 21(1):272. PubMed ID: 34865617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
    Frederiksen LSF; Zhang Y; Foged C; Thakur A
    Front Immunol; 2020; 11():1817. PubMed ID: 32793245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of vaccination on the COVID-19 pandemic in U.S. states.
    Chen X; Huang H; Ju J; Sun R; Zhang J
    Sci Rep; 2022 Jan; 12(1):1554. PubMed ID: 35091640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lockdown Efficacy in Controlling the Spread of COVID-19 May Be Waning Due to Decline in Public Compliance, Especially among Unvaccinated Individuals: A Cross-Sectional Study in Israel.
    Bodas M; Adini B; Jaffe E; Kaim A; Peleg K
    Int J Environ Res Public Health; 2022 Apr; 19(9):. PubMed ID: 35564341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. R
    Elsaid M; Nasef MA; Huy NT
    Hum Vaccin Immunother; 2021 Nov; 17(11):3850-3854. PubMed ID: 34612165
    [No Abstract]   [Full Text] [Related]  

  • 19. Association of COVID-19 Misinformation with Face Mask Wearing and Social Distancing in a Nationally Representative US Sample.
    Hornik R; Kikut A; Jesch E; Woko C; Siegel L; Kim K
    Health Commun; 2021 Jan; 36(1):6-14. PubMed ID: 33225745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Projected COVID-19 epidemic in the United States in the context of the effectiveness of a potential vaccine and implications for social distancing and face mask use.
    Shen M; Zu J; Fairley CK; Pagán JA; An L; Du Z; Guo Y; Rong L; Xiao Y; Zhuang G; Li Y; Zhang L
    Vaccine; 2021 Apr; 39(16):2295-2302. PubMed ID: 33771391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.